Sort
51,593 grants matching “hepatitis”
Humoral immunity after CAR-T cell therapy for B cell malignancies: The HICAR Study
$662,560Joshua Aiden Hill · Fred Hutchinson Cancer Research Center · U01 · FY2021 · CA
Rhesus HHV-8 homologue in AIDS-related malignancies
$662,442Scott W Wong · Oregon Health & Science University · R01 · FY2013 · CA
Role of IRF3 in Energy and Glucose Homeostasis
$662,216Evan D Rosen · Beth Israel Deaconess Medical Center · R01 · FY2021 · DK
HCV-specific T cell response
$662,172Christopher M. Walker · Research Inst Nationwide Children'S Hosp · R37 · FY2014 · AI
Novel Determinants for Progression of Non-Alcoholic Fatty Liver Disease to Hepatocellular Carcinoma and Other Health Outcomes
$662,119Jian-Min Yuan · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · CA
Applying a Human Liver Microphysiology System to Develop Therapeutic Strategies for Non-Alcoholic Fatty Liver Disease (NAFLD)
$662,067D. Lansing Taylor · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · DK
Novel mouse models of hepatitis B virus infection and replication
$662,025Guangxiang George Luo · Wake Forest University Health Sciences · R01 · FY2024 · AI
Role of IRF3 in Energy and Glucose Homeostasis
$661,923Evan D Rosen · Beth Israel Deaconess Medical Center · R01 · FY2022 · DK
TOPMed Omics of Type 2 Diabetes and Quantitative Traits
$661,878Alisa Knodle Manning · Massachusetts General Hospital · UM1 · FY2025 · DK
Discovery of novel therapeutic targets for NASH through deep phenotyping of human knockouts and mechanistic studies
$661,802Danish Saleheen · Columbia University Health Sciences · R01 · FY2023 · DK
Discovery of novel therapeutic targets for NASH through deep phenotyping of human knockouts and mechanistic studies
$661,802Ira A Tabas · Columbia University Health Sciences · R01 · FY2025 · DK
Rational design and B cell responses of HIV epitope vaccines
$661,769Jiang Zhu · Scripps Research Institute, The · R01 · FY2017 · AI
Health Services Research: Extended Release Naltrexone for Opioid-Dependent Youth
$661,668Shannon Gwin Mitchell · Friends Research Institute, Inc. · R01 · FY2014 · DA
Developing and Automating an Extracellular Vesicle-Based Test for Early Detection of Hepatocellular Carcinoma
$661,609Hsian-Rong Tseng · Eximius Diagnostics Corp · R44 · FY2025 · CA
Developing and Automating an Extracellular Vesicle-Based Test for Early Detection of Hepatocellular Carcinoma
$661,609Hsian-Rong Tseng · Eximius Diagnostics Corp · R44 · FY2023 · CA
Developing and Automating an Extracellular Vesicle-Based Test for Early Detection of Hepatocellular Carcinoma
$661,609Hsian-Rong Tseng · Eximius Diagnostics Corp · R44 · FY2024 · CA
Community Developed Technology-Based Messaging to Increase SARS-CoV-2 Vaccine Uptake Among People Who Inject Drugs
$661,600Ian David Aronson · New York University · R01 · FY2022 · DA
MR-Image Guided Focused Ultrasound for Treatment of Liver and Renal Cancer
$661,577Kim Butts Pauly · Stanford University · R01 · FY2009 · CA
Metabolic Mechanisms of Naphthalene Toxicity in Lung
$661,562Xinxin Ding · University Of Arizona · R01 · FY2025 · ES
HIV HCV Coinfection Antiviral Therapy and Fibrosis
$661,531David L Thomas · Johns Hopkins University · R37 · FY2010 · DA
RESEARCH CORE
$661,529Chau Trinh-Shevrin · New York University School Of Medicine · P60 · FY2010 · MD
Click Chemistry-Mediated Surface Protein Assay for Quantifying Subpopulations of Hepatocellular Carcinoma-associated Extracellular Vesicles
$661,505Yazhen Zhu · University Of California Los Angeles · R01 · FY2025 · CA
Surgical or Medical Treatment for Pediatric Type 2 Diabetes (ST2OMP)
$661,485Michael A Helmrath · Cincinnati Childrens Hosp Med Ctr · R01 · FY2021 · DK
Alcohol, iNOS upregulation, leaky gut & liver disease
$661,397Ali Keshavarzian · Rush University Medical Center · R01 · FY2007 · AA
1/2 Alcohol Associated Comorbidities and Microbiome Evaluation in HIV (ACME HIV)
$661,394Matthew S Freiberg · Vanderbilt University Medical Center · U01 · FY2021 · AA